Inflammatory Bowel Disease (IBD)
Immunology·MeSH: Inflammatory Bowel Diseases
Prevalence
0.1 / 100K
9 drugs in development·8 companies·6 clinical trials
Drug Pipeline by Phase
Phase 2(3)
Phase 1(3)
Preclinical(2)
Unknown(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Inflammatory Bowel Disease (IBD)?
BioSniper tracks 9 drugs in development for Inflammatory Bowel Disease (IBD) across 8 companies.
How many clinical trials target Inflammatory Bowel Disease (IBD)?
There are 6 clinical trials targeting Inflammatory Bowel Disease (IBD) tracked by BioSniper.
What is the prevalence of Inflammatory Bowel Disease (IBD)?
The estimated prevalence of Inflammatory Bowel Disease (IBD) is approximately 0.1 per 100,000 population.
Deep-dive into Inflammatory Bowel Disease (IBD)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis